Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs

Bullboard Posts

Post by goldboy1on Oct 02, 2007 3:44pm

255 Views

Post# 13509149

2

Most of Halo’s 6 deposits are 100% owned with the exception of 2 being JV with Hud Bay. Halo has 11million Tons of historic resource grading 1% Copper and 1% Zinc. All of HLO’s land is consolidated, not just a lot of pieces. It’s near surface (Open Pittable) all infrastructure is in place including a railway that runs right through to Hud Bay.

Bullboard Posts

Morning Market Outlook for Nov. 7, 2024